IL299894A - Anti-idiotypic antibodies against anti-GPRC5D antibodies - Google Patents
Anti-idiotypic antibodies against anti-GPRC5D antibodiesInfo
- Publication number
- IL299894A IL299894A IL299894A IL29989423A IL299894A IL 299894 A IL299894 A IL 299894A IL 299894 A IL299894 A IL 299894A IL 29989423 A IL29989423 A IL 29989423A IL 299894 A IL299894 A IL 299894A
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- gprc5d
- idiotypic
- antibodies against
- idiotypic antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063053286P | 2020-07-17 | 2020-07-17 | |
| PCT/IB2021/056418 WO2022013819A1 (en) | 2020-07-17 | 2021-07-15 | Anti-idiotypic antibodies against anti-gprc5d antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299894A true IL299894A (en) | 2023-03-01 |
Family
ID=77499865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299894A IL299894A (en) | 2020-07-17 | 2021-07-15 | Anti-idiotypic antibodies against anti-GPRC5D antibodies |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12030937B2 (enExample) |
| EP (1) | EP4225801A1 (enExample) |
| JP (1) | JP7844430B2 (enExample) |
| CN (1) | CN115884987A (enExample) |
| CA (1) | CA3189562A1 (enExample) |
| IL (1) | IL299894A (enExample) |
| WO (1) | WO2022013819A1 (enExample) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US6265150B1 (en) | 1995-06-07 | 2001-07-24 | Becton Dickinson & Company | Phage antibodies |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| WO2001058479A1 (en) | 2000-02-08 | 2001-08-16 | The Penn State Research Foundation | Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| JP5838021B2 (ja) | 2005-04-15 | 2015-12-24 | マクロジェニクス，インコーポレーテッド | 共有結合型ダイアボディとその使用 |
| US9963510B2 (en) | 2005-04-15 | 2018-05-08 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| HRP20200583T1 (hr) * | 2015-03-20 | 2020-07-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Protutijela koja neutraliziraju gp120 i njihova upotreba |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| MA45784A (fr) * | 2016-07-29 | 2019-06-05 | Juno Therapeutics Inc | Anticorps anti-idiotypes dirigés contre anti-cd19 anticorps |
| TW201837174A (zh) * | 2017-02-07 | 2018-10-16 | 日商第一三共股份有限公司 | 抗ｇｐｒｃ５ｄ抗體及包含該抗體之分子 |
| US12077592B2 (en) * | 2019-01-18 | 2024-09-03 | Janssen Biotech, Inc. | GPRC5D chimeric antigen receptors and cells expressing the same |
| WO2021113780A1 (en) | 2019-12-06 | 2021-06-10 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods |
-
2021
- 2021-07-15 WO PCT/IB2021/056418 patent/WO2022013819A1/en not_active Ceased
- 2021-07-15 CN CN202180049442.3A patent/CN115884987A/zh active Pending
- 2021-07-15 JP JP2023503042A patent/JP7844430B2/ja active Active
- 2021-07-15 CA CA3189562A patent/CA3189562A1/en active Pending
- 2021-07-15 US US17/376,874 patent/US12030937B2/en active Active
- 2021-07-15 IL IL299894A patent/IL299894A/en unknown
- 2021-07-15 EP EP21759387.0A patent/EP4225801A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3189562A1 (en) | 2022-01-20 |
| US12030937B2 (en) | 2024-07-09 |
| US20220064284A1 (en) | 2022-03-03 |
| WO2022013819A1 (en) | 2022-01-20 |
| CN115884987A (zh) | 2023-03-31 |
| EP4225801A1 (en) | 2023-08-16 |
| JP7844430B2 (ja) | 2026-04-13 |
| JP2023535684A (ja) | 2023-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3872091T3 (pl) | Przeciwciała przeciw sars-cov-2 | |
| IL291068A (en) | Anti-cd73 antibodies | |
| IL289112A (en) | Antibodies against tigit | |
| GB201905150D0 (en) | Ant-ige antibodies | |
| IL308741A (en) | Anti-SIRP-alpha antibodies | |
| PT4214240T (pt) | Anticorpos anti-ccr8 | |
| GB202105110D0 (en) | Anti-CD73 antibodies | |
| IL284584A (en) | Anti-tigit antibodies | |
| GB2581174B (en) | Antibodies against hEPCR | |
| GB202111905D0 (en) | Antibodies | |
| IL300142A (en) | Anti-IL13Ralpha2 antibodies | |
| GB202014851D0 (en) | SARS-COV-2 antibodies | |
| IL299890A (en) | Anti-idiotypic antibodies against anti-KLK2 antibodies | |
| GB201917480D0 (en) | Antibodies | |
| GB201900732D0 (en) | Antibodies | |
| GB202008022D0 (en) | Antibodies | |
| IL308782A (en) | Antibodies | |
| IL308100A (en) | Antibodies | |
| GB202102227D0 (en) | Antibodies | |
| IL289160A (en) | Anti-angpt2 antibodies | |
| PL4025612T3 (pl) | Przeciwciała anty-fukozylo-gm1 | |
| GB2598698B (en) | Affinity-maturated anti-ASICIa antibodies | |
| HK40110379A (en) | Anti-idiotypic antibodies against anti-cd79b antibodies | |
| HK40098163A (en) | Anti-idiotypic antibodies against anti-gprc5d antibodies | |
| HK40095754A (en) | Anti-idiotypic antibodies against anti-klk2 antibodies |